Logo
x

Search category

Subscribe Now

Dr. Reddy

Dr. Reddy’s Reports BLA Acceptance for DRL_RI, a Proposed Biosimilar Rituximab by the US FDA, EMA and MHRA

Dr. Reddy’s Reports BLA Acceptance for DRL_RI, a Proposed Biosimilar Rituximab by the US FDA, EMA and MHRA

  • July 13, 2023
Insights+ Key Biosimilars Events of June 2023

Insights+ Key Biosimilars Events of June 2023

  • July 6, 2023
Dr. Reddy Reports the Completion of the P-I Study of DRL_TC, a Proposed Biosimilar of Tocilizumab for Rheumatoid Arthritis

Dr. Reddy Reports the Completion of the P-I Study of DRL_TC, a Proposed Biosimilar of Tocilizumab for Rheumatoid Arthritis

  • June 5, 2023
Dr. Reddy’s Reports the Completion of Clinical Studies of Rituximab Biosimilar

Dr. Reddy’s Reports the Completion of Clinical Studies of Rituximab Biosimilar

  • January 20, 2023
Dr. Reddy's Laboratories Entered into a License and Distribution Agreement with CardiaCare to Commercialize Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation

Dr. Reddy's Laboratories Entered into a License and Distribution Agreement with CardiaCare to Commercialize Digital Neuromodulatio...

  • December 19, 2022
Dr. Reddy Reports the Completion of P-I Study for DRL_TC, a Proposed Biosimilar of Tocilizumab to Treat Active Rheumatoid Arthritis

Dr. Reddy Reports the Completion of P-I Study for DRL_TC, a Proposed Biosimilar of Tocilizumab to Treat Active Rheumatoid Arthriti...

  • December 19, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.